Digital Health: Significant FDA Policy Developments In 2022

In 2022, FDA retreated from a flexible approach to its regulation of digital health in two key areas: (1) its PreCertification Program for software as a medical device (SaMD) and (2) its guidance...

Related Keywords

Scott Gottlieb , Software Precertification Program , Precertification Program , International Medical Device Regulators Forum , Precert Program , Health It Report Proposed Strategy , Software Precertification Pre , Framework For Conducting The Pilot Program , International Medical Device , Drug Administration Staff , Clinical Decision Support Software , Enforcement Discretion , Drug Administration , Cert Program , Clinical Decision Support Software Guidance , Patient Decision Support Software , Unworkable Program , Clinical Decision Support , Software Precertification , Pre Cert Program , Excellence Appraisal , Review Determination , Streamlined Review , Working Model , Excellence Approval , Federal Food , Cosmetic Act , Test Plan , Key Performance Indicators , Final Guidance , Clinical Decisions Support , Century Cures Act , Limited Enforcement , Pilot Program , Ongoing Activities , New Steps , Empower Consumers , Advance Digital Healthcare , Cert Report , Proposed Strategy , Risk Based Framework , Decision Support Software Guidance , Draft Guidance , Decision Support Software , Possible Framework , Risk Categorization , International Medical Device Regulators , Mondaq , Digital Health Significant Fda Policy Developments In 2022 , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law , Iotechnology Amp Nanotechnology , ,